Related Experiment Videos
[Clinical trial of cefpiramide in the gynecological field]
Abstract:
Cefpiramide (CPM) was administrated intramuscularly to 27 cases of gynecological infections to evaluate its clinical efficacy and safety and the following results wee obtained. CPM was effective to all the cases of gynecological infections, and excellent was seen in 14 cases and good was seen in 13 cases. CPM eliminated 75% of clinical isolates. Laboratory tests were performed to blood samples and functions of liver and kidney before and after CPM treatment. Elevation of GPT was observed in 2 cases but required no treatment.
Insights
Cefpiramide (CPM) demonstrated high efficacy in treating gynecological infections, showing excellent or good results in all 27 patients. This antibiotic effectively eradicated 75% of clinical isolates with minimal side effects.
Area of Science:
- Infectious Diseases
- Pharmacology
- Gynecology
Context:
- Gynecological infections pose significant health challenges.
- Evaluating novel antibiotic treatments is crucial for patient outcomes.
Purpose:
- To assess the clinical efficacy and safety of Cefpiramide (CPM) in treating gynecological infections.
- To determine the microbiological impact of CPM on common pathogens.
Summary:
- Cefpiramide (CPM) was administered intramuscularly to 27 patients with gynecological infections.
- All patients showed positive responses, with 14 achieving excellent and 13 good outcomes.
- CPM successfully eliminated 75% of identified clinical isolates.
- Laboratory tests revealed transient GPT elevation in two cases, resolving without intervention.
Impact:
- Cefpiramide (CPM) presents a safe and effective therapeutic option for gynecological infections.
- The study supports the use of CPM in clinical practice for managing these infections.
- Further research could explore CPM's role in broader infectious disease contexts.